ena-STUDY-Aberdeen University-03-10-2014-03:44:48:441-705
The fungal microbiota of de-novo paediatric inflammatory bowel disease
Inflammatory bowel disease (IBD) is characterised by an inappropriate chronic immune response against the resident gut microbiota. This may be on account of distinct changes in the gut microbiota termed as dysbiosis. The role of fungi in this altered luminal environment has been scarcely reported. We have studied the fungal microbiome in de-novo paediatric IBD patients utilising next generation sequencing and compared with adult disease and normal controls. We report a distinct difference in fungal species with Ascomycota predominating in control subjects compared to Basidiomycota dominance in children with IBD, which could be as a result of altered tolerance in these patients.
Inflammatory bowel disease (IBD) is characterised by an inappropriate chronic immune response against the resident gut microbiota. This may be on account of distinct changes in the gut microbiota termed as dysbiosis. The role of fungi in this altered luminal environment has been scarcely reported. We have studied the fungal microbiome in de-novo paediatric IBD patients utilising next generation sequencing and compared with adult disease and normal controls. We report a distinct difference in fungal species with Ascomycota predominating in control subjects compared to Basidiomycota dominance in children with IBD, which could be as a result of altered tolerance in these patients.